Herpes simplex virus infection in women in the WIHS: Epidemiology and effect of antiretroviral therapy on clinical manifestations

Niloufar Ameli, Peter Bacchetti, Rhoda Ashley Morrow, Nancy A. Hessol, Timothy Wilkin, Mary Young, Mardge Cohen, Howard Minkoff, Stephen J Gange, Ruth M. Greenblatt

Research output: Contribution to journalArticle

Abstract

Objective: To determine the prevalence of infection with herpes simplex virus types 1 (HSV-1) and 2 (HSV-2) among women with and at high risk for HIV infection, and to evaluate the effect of HAART on the recurrence of genital lesions. Methods: We evaluated the epidemiology and clinical manifestations associated with HSV-1 and HSV-2 among 1796 HIV-infected and 476 HIV-uninfected women enrolled in a multisite cohort study. Serum antibodies to HSV-1 and HSV-2 at baseline and self-reported history of genital herpes, reports of recent genital sores and presence of genital ulcers on examination, and use of HAART regimen at each study visit were analyzed. Results: Reactivity to HSV-1 only and HSV-2 only was detected in 18% and 20% of HIV-infected, and in 28% and 18% of HIV-uninfected participants respectively; 58% of HIV-infected women and 45% of HIV-uninfected women were seropositive for both HSV types. Reactivity to HSV-2 was associated with increasing age, more male sexual partners, earlier sexual debut, African-American race, Latina ethnicity, less education and lower income. HIV-uninfected women reported significantly fewer genital sores than HIV-infected women who had used HAART for at least 1 year and had optimal CD4 cell gain and viral suppression (adjusted odds ratio (OR), 0.19; 95% confidence interval (CI), 0.13-0.28). Conclusion: Use of HAART and subsequent immune recovery does not completely eliminate the effect of HIV infection on genital lesions among women with concurrent HSV-2 infection.

Original languageEnglish (US)
Pages (from-to)1051-1058
Number of pages8
JournalAIDS
Volume20
Issue number7
DOIs
StatePublished - Apr 2006

Fingerprint

Human Herpesvirus 1
Virus Diseases
Simplexvirus
Epidemiology
Human Herpesvirus 2
HIV
Highly Active Antiretroviral Therapy
Therapeutics
HIV Infections
Herpes Genitalis
Sexual Partners
Infection
Hispanic Americans
African Americans
Ulcer
Cohort Studies
Odds Ratio
Confidence Intervals
Education
Recurrence

Keywords

  • Genital ulcer
  • HAART
  • HIV infection
  • HSV
  • Women

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Ameli, N., Bacchetti, P., Morrow, R. A., Hessol, N. A., Wilkin, T., Young, M., ... Greenblatt, R. M. (2006). Herpes simplex virus infection in women in the WIHS: Epidemiology and effect of antiretroviral therapy on clinical manifestations. AIDS, 20(7), 1051-1058. https://doi.org/10.1097/01.aids.0000222078.75867.77

Herpes simplex virus infection in women in the WIHS : Epidemiology and effect of antiretroviral therapy on clinical manifestations. / Ameli, Niloufar; Bacchetti, Peter; Morrow, Rhoda Ashley; Hessol, Nancy A.; Wilkin, Timothy; Young, Mary; Cohen, Mardge; Minkoff, Howard; Gange, Stephen J; Greenblatt, Ruth M.

In: AIDS, Vol. 20, No. 7, 04.2006, p. 1051-1058.

Research output: Contribution to journalArticle

Ameli, N, Bacchetti, P, Morrow, RA, Hessol, NA, Wilkin, T, Young, M, Cohen, M, Minkoff, H, Gange, SJ & Greenblatt, RM 2006, 'Herpes simplex virus infection in women in the WIHS: Epidemiology and effect of antiretroviral therapy on clinical manifestations', AIDS, vol. 20, no. 7, pp. 1051-1058. https://doi.org/10.1097/01.aids.0000222078.75867.77
Ameli, Niloufar ; Bacchetti, Peter ; Morrow, Rhoda Ashley ; Hessol, Nancy A. ; Wilkin, Timothy ; Young, Mary ; Cohen, Mardge ; Minkoff, Howard ; Gange, Stephen J ; Greenblatt, Ruth M. / Herpes simplex virus infection in women in the WIHS : Epidemiology and effect of antiretroviral therapy on clinical manifestations. In: AIDS. 2006 ; Vol. 20, No. 7. pp. 1051-1058.
@article{a38c552de54749648f0b219303847a17,
title = "Herpes simplex virus infection in women in the WIHS: Epidemiology and effect of antiretroviral therapy on clinical manifestations",
abstract = "Objective: To determine the prevalence of infection with herpes simplex virus types 1 (HSV-1) and 2 (HSV-2) among women with and at high risk for HIV infection, and to evaluate the effect of HAART on the recurrence of genital lesions. Methods: We evaluated the epidemiology and clinical manifestations associated with HSV-1 and HSV-2 among 1796 HIV-infected and 476 HIV-uninfected women enrolled in a multisite cohort study. Serum antibodies to HSV-1 and HSV-2 at baseline and self-reported history of genital herpes, reports of recent genital sores and presence of genital ulcers on examination, and use of HAART regimen at each study visit were analyzed. Results: Reactivity to HSV-1 only and HSV-2 only was detected in 18{\%} and 20{\%} of HIV-infected, and in 28{\%} and 18{\%} of HIV-uninfected participants respectively; 58{\%} of HIV-infected women and 45{\%} of HIV-uninfected women were seropositive for both HSV types. Reactivity to HSV-2 was associated with increasing age, more male sexual partners, earlier sexual debut, African-American race, Latina ethnicity, less education and lower income. HIV-uninfected women reported significantly fewer genital sores than HIV-infected women who had used HAART for at least 1 year and had optimal CD4 cell gain and viral suppression (adjusted odds ratio (OR), 0.19; 95{\%} confidence interval (CI), 0.13-0.28). Conclusion: Use of HAART and subsequent immune recovery does not completely eliminate the effect of HIV infection on genital lesions among women with concurrent HSV-2 infection.",
keywords = "Genital ulcer, HAART, HIV infection, HSV, Women",
author = "Niloufar Ameli and Peter Bacchetti and Morrow, {Rhoda Ashley} and Hessol, {Nancy A.} and Timothy Wilkin and Mary Young and Mardge Cohen and Howard Minkoff and Gange, {Stephen J} and Greenblatt, {Ruth M.}",
year = "2006",
month = "4",
doi = "10.1097/01.aids.0000222078.75867.77",
language = "English (US)",
volume = "20",
pages = "1051--1058",
journal = "AIDS",
issn = "0269-9370",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Herpes simplex virus infection in women in the WIHS

T2 - Epidemiology and effect of antiretroviral therapy on clinical manifestations

AU - Ameli, Niloufar

AU - Bacchetti, Peter

AU - Morrow, Rhoda Ashley

AU - Hessol, Nancy A.

AU - Wilkin, Timothy

AU - Young, Mary

AU - Cohen, Mardge

AU - Minkoff, Howard

AU - Gange, Stephen J

AU - Greenblatt, Ruth M.

PY - 2006/4

Y1 - 2006/4

N2 - Objective: To determine the prevalence of infection with herpes simplex virus types 1 (HSV-1) and 2 (HSV-2) among women with and at high risk for HIV infection, and to evaluate the effect of HAART on the recurrence of genital lesions. Methods: We evaluated the epidemiology and clinical manifestations associated with HSV-1 and HSV-2 among 1796 HIV-infected and 476 HIV-uninfected women enrolled in a multisite cohort study. Serum antibodies to HSV-1 and HSV-2 at baseline and self-reported history of genital herpes, reports of recent genital sores and presence of genital ulcers on examination, and use of HAART regimen at each study visit were analyzed. Results: Reactivity to HSV-1 only and HSV-2 only was detected in 18% and 20% of HIV-infected, and in 28% and 18% of HIV-uninfected participants respectively; 58% of HIV-infected women and 45% of HIV-uninfected women were seropositive for both HSV types. Reactivity to HSV-2 was associated with increasing age, more male sexual partners, earlier sexual debut, African-American race, Latina ethnicity, less education and lower income. HIV-uninfected women reported significantly fewer genital sores than HIV-infected women who had used HAART for at least 1 year and had optimal CD4 cell gain and viral suppression (adjusted odds ratio (OR), 0.19; 95% confidence interval (CI), 0.13-0.28). Conclusion: Use of HAART and subsequent immune recovery does not completely eliminate the effect of HIV infection on genital lesions among women with concurrent HSV-2 infection.

AB - Objective: To determine the prevalence of infection with herpes simplex virus types 1 (HSV-1) and 2 (HSV-2) among women with and at high risk for HIV infection, and to evaluate the effect of HAART on the recurrence of genital lesions. Methods: We evaluated the epidemiology and clinical manifestations associated with HSV-1 and HSV-2 among 1796 HIV-infected and 476 HIV-uninfected women enrolled in a multisite cohort study. Serum antibodies to HSV-1 and HSV-2 at baseline and self-reported history of genital herpes, reports of recent genital sores and presence of genital ulcers on examination, and use of HAART regimen at each study visit were analyzed. Results: Reactivity to HSV-1 only and HSV-2 only was detected in 18% and 20% of HIV-infected, and in 28% and 18% of HIV-uninfected participants respectively; 58% of HIV-infected women and 45% of HIV-uninfected women were seropositive for both HSV types. Reactivity to HSV-2 was associated with increasing age, more male sexual partners, earlier sexual debut, African-American race, Latina ethnicity, less education and lower income. HIV-uninfected women reported significantly fewer genital sores than HIV-infected women who had used HAART for at least 1 year and had optimal CD4 cell gain and viral suppression (adjusted odds ratio (OR), 0.19; 95% confidence interval (CI), 0.13-0.28). Conclusion: Use of HAART and subsequent immune recovery does not completely eliminate the effect of HIV infection on genital lesions among women with concurrent HSV-2 infection.

KW - Genital ulcer

KW - HAART

KW - HIV infection

KW - HSV

KW - Women

UR - http://www.scopus.com/inward/record.url?scp=33646381383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646381383&partnerID=8YFLogxK

U2 - 10.1097/01.aids.0000222078.75867.77

DO - 10.1097/01.aids.0000222078.75867.77

M3 - Article

C2 - 16603858

AN - SCOPUS:33646381383

VL - 20

SP - 1051

EP - 1058

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 7

ER -